CLL Nr | Age/sex | Rai stage | LDT | WBC/Ald | Change of stage | Time to 1st treatment | Survival time after diagnosis |
---|---|---|---|---|---|---|---|
171 | 66/F | I | <12 mo | 25.4/NA | To III at 7 y | Within 2 y | 8+ y |
334 | 54/M | II | ∼12 mo | 38.4/30.91 | To IV | At 2 y | 4+ y |
394 | 53/M | I | >12 mo | 15.9/10.0 | None | None | 3+ y |
521 | 65/M | II | NA | NA | NA | At 5 y | 5+ y |
559 | 48/M | 0 | <12 mo | 14/6.5 | Stage I in 3.5 y | At 3 y | 6+ y |
561 | 57/M | IV | NA | 13.7/9.09 | NA | From diagnosis | 5+ y |
569 | 51/M | II | NA | 77.9/60.0 | NA | NA | Aliveb |
349 | 59/F | 0 | <12 mo | 10.0/NA | NA | NA | Aliveb |
124 | 68/M | 0 | >12 mo | 12.6/59 | To IV at 5 y | Within 3 y | ∼10 y |
189 | 51/M | I | <12 mo | 16.3/NA | To IV at 3 y | At 4 y | 7+ y |
567 | 55/F | 0 | >12 mo | 11.4/6.4 | None | None | 4+ y |